1 / 20

Endometrial Cancer

Oncology Registrars’ Forum. “Best of Five”. Endometrial Cancer. May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust. Click Here For First Question. Question 1.

teri
Télécharger la présentation

Endometrial Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Oncology Registrars’ Forum “Best of Five” Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question

  2. Question 1 • A 64 year old women presented to her GP with an episode of post-menopausal bleeding. She was referred to a surgical gynaecological oncologist who performed a hysteroscopy and biopsy. What is the most likely diagnosis? Large cell, non-keratinizing squamous cell carcinoma of the cervix Adenocarcinoma of the cervix Endometrioid carcinoma of the endometrium Serous carcinoma of the endometrium Clear cell carcinoma of the endometrium Click Here For Answer

  3. Question 1 • A 64 year old women presented to her GP with an episode of post-menopausal bleeding. She was referred to a surgical gynaecological oncologist who performed a hysteroscopy and biopsy. What is the most likely diagnosis? Large cell, non-keratinizing squamous cell carcinoma of the cervix Adenocarcinoma of the cervix Endometrioid carcinoma of the endometrium Serous carcinoma of the endometrium Clear cell carcinoma of the endometrium Click Here For Next Question

  4. Question 2 • A 50 year old women underwent a TAH, BSO and bilateral pelvic lymphadenectomy for endometrial cancer. On histological review she was found to have a grade 2 endometrial adenocarcinoma invading into the outer half of the myometrium. A few cervical glands were involved and there were also small deposits in the omentum. What stage is her disease? Stage IIB Stage IIIA Stage IIIB Stage IIIC Stage IV Click Here For Answer

  5. Question 2 • A 50 year old women underwent a TAH, BSO and bilateral pelvic lymphadenectomy for endometrial cancer. On histological review she was found to have a grade 2 endometrial adenocarcinoma invading into the outer half of the myometrium. A few cervical glands were involved and there were also small deposits in the omentum. What stage is her disease? Stage IIB Stage IIIA Stage IIIB Stage IIIC Stage IV Click Here For Next Question

  6. Question 3 • A 35 year old women was diagnosed with a stage IIB endometrial carcinoma and underwent a TAH, BSO and bilateral pelvic lymphadenectomy. What is the most appropriate adjuvant treatment? No adjuvant treatment Vaginal brachytherapy only Pelvic EBRT only Pelvic EBRT and vaginal brachytherapy Chemotherapy followed by pelvic EBRT and vaginal brachytherapy Click Here For Answer

  7. Question 3 • A 35 year old women was diagnosed with a stage IIB endometrial carcinoma and underwent a TAH, BSO and bilateral pelvic lymphadenectomy. What is the most appropriate adjuvant treatment? No adjuvant treatment Vaginal brachytherapy only Pelvic EBRT only Pelvic EBRT and vaginal brachytherapy Chemotherapy followed by pelvic EBRT and vaginal brachytherapy Click Here For Next Question

  8. Question 4 • A 42 year old woman underwent a TAH, BSO and bilateral pelvic lymphadenectomy and was found to have stage IIIC endometrial adenocarcinoma. She is offered adjuvant chemotherapy. Which drug or drug-combination is most likely to cause peripheral neuropathy? Single-agent carboplatin Carboplatin / paclitaxel Carboplatin / docetaxel Cisplatin / docetaxel Cisplatin / paclitaxel Click Here For Answer

  9. Question 4 • A 42 year old woman underwent a TAH, BSO and bilateral pelvic lymphadenectomy and was found to have stage IIIC endometrial adenocarcinoma. She is offered adjuvant chemotherapy. Which drug or drug-combination is most likely to cause peripheral neuropathy? Single-agent carboplatin Carboplatin / paclitaxel Carboplatin / docetaxel Cisplatin / docetaxel Cisplatin / paclitaxel Click Here For Next question

  10. Question 5 • A 48 year old woman is offered chemotherapy for stage IV endometrial cancer. Which drug combination is most active in endometrial carcinoma? Doxorubicin / carboplatin Doxorubicin / cisplatin Doxorubicin / paclitaxel / cisplatin Paclitaxel / cisplatin Doxorubicin / carboplatin / paclitaxel Click Here For Answer

  11. Question 5 • A 48 year old woman is offered chemotherapy for stage IV endometrial cancer. Which drug combination is most active in endometrial carcinoma? Doxorubicin / carboplatin Doxorubicin / cisplatin Doxorubicin / paclitaxel / cisplatin Paclitaxel / cisplatin Doxorubicin / carboplatin / paclitaxel Click Here For Next Question

  12. Question 6 • A 63 year old woman is offered radiotherapy as part of the ASTEC study. Which of the following FIGO stages, if any, is suitable for entry into the trial? Stage IB G2 Stage IC G2 Stage IIA G2 Stage IIB G2 None of the above Click Here For Answer

  13. Question 6 • A 63 year old woman is offered radiotherapy as part of the ASTEC study. Which of the following FIGO stages, if any, is suitable for entry into the trial? Stage IB G2 Stage IC G2 Stage IIA G2 Stage IIB G2 None of the above Click Here For Next Question

  14. Question 7 • A 67 year old woman is offered adjuvant EBRT and brachytherapy treatment for stage II endometrial carcinoma. Which is the most suitable dose? 45Gy in 25# EBRT + 15Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 20Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 25Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 15Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 20Gy LDR brachytherapy to 0.5cm Click Here For Answer

  15. Question 7 • A 67 year old woman is offered adjuvant EBRT and brachytherapy treatment for stage II endometrial carcinoma. Which is the most suitable dose? 45Gy in 25# EBRT + 15Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 20Gy LDR brachytherapy to 0.5cm 45Gy in 25# EBRT + 25Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 15Gy LDR brachytherapy to 0.5cm 50.4Gy in 28# EBRT + 20Gy LDR brachytherapy to 0.5cm Click Here For Next Question

  16. Question 8 • A 45 year old woman has a diagnosis of serous carcinoma of the endometrium on biopsy. A surgical gynaecological oncologist operates. What is the most suitable operation? TAH & BSO only TAH & BSO & bilateral pelvic lymphadenectomy (BPL) TAH & BSO & omentectomy TAH & BSO & BPL & omentectomy Staging laparotomy Click Here For Answer

  17. Question 8 • A 45 year old woman has a diagnosis of serous carcinoma of the endometrium on biopsy. A surgical gynaecological oncologist operates. What is the most suitable operation? TAH & BSO only TAH & BSO & bilateral pelvic lymphadenectomy (BPL) TAH & BSO & omentectomy TAH & BSO & BPL & omentectomy Staging laparotomy Click Here For Next Question

  18. Question 9 • A 43 year old woman has a diagnosis of stage IIIA serous carcinoma of the endometrium. What is the most suitable adjuvant treatment? No adjuvant treatment Radiotherapy only Chemotherapy only Chemotherapy then radiotherapy Radiotherapy then chemotherapy Click Here For Answer

  19. Question 9 • A 43 year old woman has a diagnosis of stage IIIA serous carcinoma of the endometrium. What is the most suitable adjuvant treatment? No adjuvant treatment Radiotherapy only Chemotherapy only Chemotherapy then radiotherapy Radiotherapy then chemotherapy Click Here For Next Slide

  20. The End

More Related